miR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in glioma cells

Journal of Neuro-Oncology

Volumn 121, Issue 1, 2015, Pages 63-72

  Zhang, Rui ^a   Luo, Hui ^a   Wang, Shuai ^a   Chen, Zhengxin ^a   Hua, Lingyang ^a   Wang, Hong Wei ^b   Chen, Wanghao ^a   Yuan, Yongsheng ^a   Zhou, Xiaobin ^a   Li, Daqian ^c   Shen, Shuying ^d   Jiang, Tao ^e,f   You, Yongping ^a,f   Liu, Ning ^a,f   Wang, Huibo ^a,f  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY   (China)

^e CAPITAL MEDICAL UNIVERSITY   (China)

^f Chinese Glioma Cooperative Group (CGCG)   (China)

Author keywords

ATF2; Glioma; Invasion; Migration; miR 622

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; MICRORNA; MICRORNA 622; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ATF2 PROTEIN, HUMAN; MIRN622 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; TUMOR GROWTH; TUMOR INVASION; ASTROCYTE; BRAIN; BRAIN TUMOR; CELL CULTURE; CELL MOTION; GENE SILENCING; GENETICS; GLIOMA; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ACTIVATING TRANSCRIPTION FACTOR 2; ASTROCYTES; BRAIN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELLS, CULTURED; GENE KNOCKDOWN TECHNIQUES; GLIOMA; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS;

EID: 84921937344     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-014-1607-y     Document Type: Article

References (24)

1. Behin A, Hoang-Xuan K, Carpentier AF, Delattre JY (2003) Primary brain tumours in adults. Lancet 361:323–331
2. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, Chin L, DePinho RA, Cavenee WK (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21:2683–2710
3. Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359:492–507
4. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJB, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO, Treatment EOR, Grp CBT, Grp RO, N.C.I.C.C. Trials (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466
5. Giese A, Bjerkvig R, Berens ME, Westphal M (2003) Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21:1624–1636
6. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297
7. MacFarlane LA, Murphy PR (2010) MicroRNA: biogenesis function and role in cancer. Curr Genomics 11:537–561
8. Hwang HW, Mendell JT (2006) MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 94:776–780
9. Yang LQ, Li Q, Wang QX, Jiang Z, Zhang L (2012) Silencing of miRNA-218 promotes migration and invasion of breast cancer via Slit2-Robo1 pathway. Biomed Pharmacother 66:535–540
10. Kloosterman WP, Plasterk RHA (2006) The diverse functions of MicroRNAs in animal development and disease. Dev Cell 11:441–450
11. Delic S, Lottmann N, Stelzl A, Liesenberg F, Wolter M, Gotze S, Zapatka M, Shiio Y, Sabel MC, Felsberg J, Reifenberger G, Riemenschneider MJ (2014) MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation. Neuro Oncol 16:179–190
12. Wang XR, Luo H, Li HL, Cao L, Wang XF, Yan W, Wang YY, Zhang JX, Jiang T, Kang CS, Liu N, You YP (2013) Overexpressed let-7a inhibits glioma cell malignancy by directly targeting K-ras, independently of PTEN. Neuro Oncol 15:1491–1501
13. Yan-nan B, Zhao-yan Y, Li-xi L, Jiang Y, Qing-jie X, Yong Z (2014) MicroRNA-21 accelerates hepatocyte proliferation in vitro via PI3K/Akt signaling by targeting PTEN. Biochem Biophys Res Commun 443:802–807
14. Li S, Xu X, Hu Z, Wu J, Zhu Y, Chen H, Mao Y, Lin Y, Luo J, Zheng X, Xie L (2013) MicroRNA-490-5p inhibits proliferation of bladder cancer by targeting c-Fos. Biochem Biophys Res Commun 441:976–981
15. Wu H, Xiao Z, Wang K, Liu W, Hao Q (2013) MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1. Biochem Biophys Res Commun 441:693–700
16. Ma Y, Qin H, Cui Y (2013) MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway. Biochem Biophys Res Commun 441:958–963
17. Deng J, Lei W, Fu JC, Zhang L, Li JH, Xiong JP (2014) Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitro. Biochem Biophys Res Commun 443:789–795
18. Han Z, Yang Q, Liu B, Wu J, Li Y, Yang C, Jiang Y (2012) MicroRNA-622 functions as a tumor suppressor by targeting K-Ras and enhancing the anticarcinogenic effect of resveratrol. Carcinogenesis 33:131–139
19. Guo XB, Jing CQ, Li LP, Zhang L, Shi YL, Wang JS, Liu JL, Li CS (2011) Down-regulation of miR-622 in gastric cancer promotes cellular invasion and tumor metastasis by targeting ING1 gene. World J Gastroenterol 17:1895–1902
20. Lopez-Bergami P, Lau E, Ronai Z (2010) Emerging roles of ATF2 and the dynamic AP1 network in cancer. Nat Rev Cancer 10:65–76
21. Kim ES, Sohn YW, Moon A (2007) TGF-beta-induced transcriptional activation of MMP-2 is mediated by activating transcription factor (ATF)2 in human breast epithelial cells. Cancer Lett 252:147–156
22. Song H, Ki SH, Kim SG, Moon A (2006) Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells. Cancer Res 66:10487–10496
23. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
24. Vlahopoulos SA, Logotheti S, Mikas D, Giarika A, Gorgoulis V, Zoumpourlis V (2008) The role of ATF-2 in oncogenesis. BioEssays 30:314–327